DCBLD2
DCBLD2 (discoidin, CUB and LCCL domain containing 2) is a membrane protein predicted to act as a signalling receptor. It is also known as CLCP1 and ESDN, and has been linked to negative regulation of cell growth and to wound healing. Browse Assay Genie's current range of DCBLD2 research reagents below, or read on for the biology behind the target.
DCBLD2 is a membrane-associated protein that is predicted to enable signalling receptor activity. Annotation places it at the cell surface and in the plasma membrane, which is consistent with a role in receiving and relaying extracellular cues. In the annotation available for this gene, DCBLD2 is involved in the negative regulation of cell growth and in wound healing, two processes that depend on how cells respond to their surroundings.
The protein takes its name from the domains it is described as containing: discoidin, CUB and LCCL. The official gene name is discoidin, CUB and LCCL domain containing 2. The same gene is also referred to by the aliases CLCP1 and ESDN, so both names are worth searching when reviewing the literature on the DCBLD2 gene or the DCBLD2 protein. The gene is catalogued as HGNC:24627, NCBI Gene 131566 and UniProt Q96PD2.
Orthologous genes are recognised in mouse and rat, both named Dcbld2, which allows the protein to be studied in common rodent models. Because the functional annotation for DCBLD2 is largely predicted rather than fully characterised, much of its biology is still an open research question, particularly the identity of its ligands and the signalling pathways it engages. Researchers working on DCBLD2 typically focus on its behaviour at the cell membrane and its effect on growth control and tissue repair.
DCBLD2 is involved in the negative regulation of cell growth, making it a candidate for studies of how membrane proteins restrain proliferation.
The gene is annotated as involved in wound healing, so DCBLD2 is relevant to work on cellular responses during tissue repair.
DCBLD2 is predicted to enable signalling receptor activity, which makes it of interest for mapping cell surface signalling and its downstream effects.
Located at the cell surface and plasma membrane, DCBLD2 offers a model for studying how discoidin, CUB and LCCL domain proteins function at the membrane.
DCBLD2 is predicted to enable signalling receptor activity and is located at the cell surface and plasma membrane. It is involved in the negative regulation of cell growth and in wound healing. Much of this annotation is predicted, so its precise molecular mechanism remains to be fully defined.
The HGNC-approved name is discoidin, CUB and LCCL domain containing 2. The gene is also known as CLCP1 and ESDN. UniProt lists the protein as discoidin, CUB and LCCL domain-containing protein 2. Searching all of these names helps when reviewing older papers on the same gene.
Yes. Orthologs named Dcbld2 are recognised in both mouse and rat, so the protein can be studied in rodent models. Check the datasheet of any product for its validated reactivity before choosing a species.
Other membrane receptors and signalling proteins relevant to cell growth control and tissue repair research.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q96PD2; product specifications from Assay Genie datasheets.